Fleetcor Technologies (FLT)
Robert W. Baird analyst David Koning maintained a Hold rating on Fleetcor Technologies on September 10 and set a price target of $312.00. The company’s shares closed last Monday at $260.01.
According to TipRanks.com, Koning is a 5-star analyst with an average return of 16.5% and a 76.5% success rate. Koning covers the Technology sector, focusing on stocks such as TELUS International (CDA), Jack Henry & Associates, and Fidelity National Info.
Currently, the analyst consensus on Fleetcor Technologies is a Hold with an average price target of $293.14.
Design Therapeutics (DSGN)
In a report issued on September 12, Joseph Schwartz from Leerink Partners maintained a Buy rating on Design Therapeutics. The company’s shares closed last Monday at $16.38, close to its 52-week low of $13.93.
According to TipRanks.com, Schwartz is a 4-star analyst with an average return of 12.7% and a 48.2% success rate. Schwartz covers the Healthcare sector, focusing on stocks such as Applied Molecular Transport, Mereo Biopharma Group Plc, and Crinetics Pharmaceuticals.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Design Therapeutics with a $39.00 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.